Following the news earlier this month that CollabRX has released a semantic clinical support tool for oncologists, CollabRX has formed a new editorial board for prostate cancer. According to the article, “CollabRx, Inc. [yesterday] announced the formation of an editorial board for prostate cancer to be led by E. David Crawford, M.D. who will serve as Chief Editor. Dr. Crawford is the distinguished Professor of Surgery, Urology, and Radiation Oncology, and head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus. He is an active clinician, researcher, and teacher who has been recognized as one of the Best Doctors in America, one of the Best Cancer Doctors, and one of the Top 20 Urologists in the country by Men’s Health Magazine. Dr. Crawford will lead a distinguished group of physicians from leading institutions such as Yale University, University of Michigan, Cleveland Clinic, Dana-Farber Cancer Institute, and others.” Read more